Our Bioanalytical Group develops and validates proprietary
and non-proprietary analytical methods to identify, quantify and characterize small
molecules, new chemical entities, and biologics from many different matrices. Mass
spectrometry methods characterize batches of protein biologics throughout the stages
of discovery, production and lot release.
Our Bioassay Group develops and validates custom
assays to evaluate the therapeutic potential of biological macromolecules. Our bioassays
are developed using the latest technologies and employed for all phases of drug
development, as well as GMP-lot release testing of biologics destined for the clinic.
Custom Biologics™ maintains a controlled storage facility that can accommodate
sample and reagent storage at 2-8°C, -40°C, -80°C, and under liquid nitrogen conditions.